Event Details
August 13, 2019
Description
Internal discussion at MCC New York regarding the update of patient care supplements to include Naloxone protocols.
Participants (1)
| Name | Type | Mentions | |
|---|---|---|---|
| associate warden | person | 28 | View Entity |
Source Documents (1)
EFTA00036891.pdf
An email correspondence dated August 13, 2019 (three days after Jeffrey Epstein's death), from the Associate Warden of MCC New York. The email discusses updating a 'Patient Care' supplement to include protocols for Naloxone (an opioid overdose reversal drug) to align with other institutions. The document includes a forwarded message from the previous day.
Related Events
Events with shared participants
The associate warden reported to the Criminal Justice Advisory Board that MDC does not mandate COVID testing for its staff.
2020-12-02 • MDC
Last revision of the Associate Warden's contact profile (20190801T110031Z).
2019-08-01 • Unknown (Likely MCC New York)
Contact record last updated
2019-08-12 • N/A
Email discussion regarding scheduling the Mortality Review for Jeffrey Epstein.
2019-08-13 • MCC New York
Associate Warden report to Criminal Justice Advisory Board.
2020-12-02 • Unknown
An incident at MCC New York generated a memo. The Associate Warden noted that the information in the memo differed from what they were verbally told. Contextually, this date corresponds to Jeffrey Epstein's first suicide attempt/incident in his cell.
2019-07-23 • MCC New York
Aftermath of Jeffrey Epstein's death (August 10, 2019). BOP staff are exchanging supportive emails regarding media scrutiny ('fake new') and the Associate Warden standing at MCC New York.
2019-08-14 • MCC New York
Aftermath of Jeffrey Epstein's death at MCC New York
2019-08-10 • MCC New York
Exchange of documents regarding Jeffrey Epstein's suicide watch (S/W) and psychology operations records, occurring two days after his death.
2019-08-12 • MCC New York
Transmission of Medical Mortality Review document for Jeffrey Epstein
2019-08-12 • MCC New York
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein event